UNfortunately I have to believe the bottom of your post sums up the activity.  I feel badly for those that bit on the previous partners deception with 5, 4 and eventually 3 cent CAD SP targets.

Is this really how Canada's #1 exchange operates?

God Bless America..depsite the clowns attempting to run it ; - )

The control is stunning, but of course if they:

(1) attended a conference more than once every 4 years (and got a slot other than 5:00pm), and or

(2) they talked about their acheivements and their in-progress results with frequent updates (other than releasing stuff via a dry news release and or key data buried in an MD&A), and or

(3) they finally took some concrete steps to up-list on a major exchange that has an appetitie for all things Biotech and especially Covid related (as opposed to just talk about it year after year, and or go the opposite way) , and or

(4) they did a better job of blue-skying the opportunity (i.e. better quantifying the future revenue streams for all products) versus always showing worst case, and subsets of revenue possiblilties,mix of currencies, etc.  (ignoring major components such as Covid, EAA, etc.)  and or

(5) got an analyst or two on board that would actually "earn" their commission and keep the investment community fully apprised and up to date....

...THEN...


it would certainly help to address the lack of volume and share price manipulation that seems to be occuring...


UNLESS...

That's what they want to happen (which seems counter-intuitive to what a BoD and Mgt group should be doing to enhance shareholder value at all times) 


MM